Suppr超能文献

肾输尿管切除术膀胱袖口处理的争议

Controversies in management of the bladder cuff at nephroureterectomy.

作者信息

Braun Avery E, Srivastava Abhishek, Maffucci Fenizia, Kutikov Alexander

机构信息

Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA.

出版信息

Transl Androl Urol. 2020 Aug;9(4):1868-1880. doi: 10.21037/tau.2020.01.17.

Abstract

Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and robotic techniques has transformed this operation, yet no level I evidence exists at present that demonstrates the superiority of one strategy over another. While new approaches to nephroureterectomy in the last decade have shifted the management paradigm to decrease the morbidity of surgery, controversy continues to surround the approach to the distal ureter and bladder cuff. Debate continues within the urologic community over which surgical approach is best when managing UTUC and how various approaches impact clinical outcomes such as intravesical recurrence, recurrence-free survival (RFS) and disease-specific mortality (DSM). When focusing on the existing treatment algorithm, key metrics of quality include (I) removal of the entire specimen , (II) minimizing the risk of tumor and urine spillage, (III) R0 resection, and (IV) water-tight closure allowing for early use of prophylactic intravesical chemotherapy. In the absence of robust evidence demonstrating a single superior approach, the urologic surgeon should base decisions on technical comfort and each patient's particular clinical circumstance.

摘要

上尿路尿路上皮癌(UTUC)约占尿路上皮癌的5%。从历史上看,高危或体积较大的低危UTUC的金标准是开放性根治性肾输尿管切除术并进行正规膀胱袖状切除术(BCE)。新型内镜、腹腔镜和机器人技术的发展改变了这一手术方式,但目前尚无一级证据表明一种策略优于另一种策略。虽然过去十年中肾输尿管切除术的新方法已将管理模式转向降低手术发病率,但围绕远端输尿管和膀胱袖状的处理方法仍存在争议。泌尿外科界对于治疗UTUC时哪种手术方法最佳以及各种方法如何影响诸如膀胱内复发、无复发生存率(RFS)和疾病特异性死亡率(DSM)等临床结果仍在继续争论。当关注现有的治疗算法时,质量的关键指标包括:(I)切除整个标本,(II)将肿瘤和尿液溢出的风险降至最低,(III)R0切除,以及(IV)水密缝合以便早期使用预防性膀胱内化疗。在缺乏有力证据证明单一最佳方法的情况下,泌尿外科医生应根据技术熟练程度和每个患者的具体临床情况做出决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f91/7475677/8de1eb17222d/tau-09-04-1868-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验